New Era of DIEP With Minimally Invasive Mastectomy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

278 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-03

Study Completion Date

2023-10-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The free deep inferior epigastric artery perforator (DIEP) flap is the gold standard in autologous breast reconstruction. Asian patients often present with a smaller body mass index with relatively insufficient tissue. To restore appropriate symmetry, a larger flap inset ratio must be transferred. Supercharging of the second vein or inclusion of bilateral pedicle is commonly required. Current paradigm shifts in mastectomy has also resulted in more minimally invasive surgeries (MIS) espousing smaller lateral incisions, leading to a significant change in available recipient vessels. This study aimed to demonstrate our experience in changing strategies of DIEP flaps following the evolution of mastectomy techniques.

Between October 2008 and March 2022, retrospective data was gathered for 278 patients who underwent breast reconstruction surgery utilizing DIEP flaps by a single plastic surgeon. These patients were divided into two distinct groups based on their operation dates, with November 2018 marking a pivotal moment when the first MIS was introduced.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Successful Microsurgical Breast Reconstruction in Minimally Invasive Mastectomy

NCT05943873

Breast Reconstruction Breast Cancer

COMPLETED

Nipple-sparing Mastectomy in Combined With Buried Flap Monitoring

NCT05560633

Breast/Surgery

COMPLETED

OPERA - Incorporating Robotic Surgery in Both Mastectomy and DIEP Flap Reconstruction

NCT06415526

Breast Cancer Mastectomy; Lymphedema

COMPLETED

Incorporating Robotic Surgery in Both Mastectomy and DIEP Flap Reconstruction

NCT05945914

Breast Cancer Breast Reconstruction

COMPLETED

Deep Inferior Epigastric Artery Flap for Breast Reconstruction

NCT05088239

Breast Cancer Perforator Flap Anti-Infectives Adverse Reaction +1 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Reconstruction Mastectomy; Lymphedema

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Individuals who underwent surgery prior to November 2018

No interventions assigned to this group

Group B

Individuals who underwent surgery after November 2018

The reference point of minimally invasive mastectomy procedure conducted

Intervention Type OTHER

November 2018 as a temporal reference point was predicated on the milestone of the medical center's inaugural minimally invasive mastectomy procedure conducted

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

The reference point of minimally invasive mastectomy procedure conducted

November 2018 as a temporal reference point was predicated on the milestone of the medical center's inaugural minimally invasive mastectomy procedure conducted

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients who underwent breast reconstruction procedures with DIEP flaps from October 2008 to March 2022.
* Patients who have a minimum follow-up duration of six months post-reconstruction.